Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

0.910
+0.0101.11%
Volume:122.50K
Turnover:110.40K
Market Cap:657.02M
PE:-2.52
High:0.940
Open:0.890
Low:0.890
Close:0.900
52wk High:2.340
52wk Low:0.890
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:0.24
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-7.67%
ROA:-7.02%
PB:0.25
PE(LYR):-2.52
PS:16.13

Loading ...

Brii Biosciences Completes Additional Share Buyback; Treasury Stock Rises to 12.92 Million Shares

Bulletin Express
·
Aug 31

Brii Biosciences Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Aug 31

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress
·
Aug 26

Brii Bio Repurchases 120,000 Shares; Treasury Stock Rises to 12.90 Million

Bulletin Express
·
Aug 25

Brii-Biosciences (BRII-B) Issues 0.26 Million New Shares Under Employee Schemes; Repurchases 0.06 Million Shares Into Treasury

Bulletin Express
·
Aug 24

BRII-B (02137) Buys Back 60,000 Shares for HK$60,300 on August 24

Stock News
·
Aug 24

Brii Biosciences Files HKEX Next-Day Disclosure, Lifts Share Capital by 255,793 Shares

Reuters
·
Aug 24

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Reuters
·
Aug 24

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

Stock News
·
Aug 21

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 21

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS
·
Aug 21

Brii Biosciences: Hy Other Income Rmb19.5 Mln

THOMSON REUTERS
·
Aug 21

Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million

Reuters
·
Aug 21

Brii Biosciences Sets 20 August 2026 Board Meeting to Review 1H26 Interim Results

Bulletin Express
·
Aug 07

Brii Biosciences Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 07

Analyzing the First Half Fiscal Revenue and Expenditure Growth Rates in 2026

Deep News
·
Jul 29

Brii Biosciences (BRII-B) Adds 46.56 Thousand New Shares in June; Confirms Public-Float Compliance

Bulletin Express
·
Jul 07

Is Brii Biosciences (HKG:2137) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
Jul 04